Ledger.Open graph →
SEC Form D · filed December 2, 2015

Iterum Therapeutics Ltd

Offering
$47.5M
Sold
$23.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DUBLIN, Ireland
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

James I. Healy · Dublin, IrelandDirectorPatrick J. Heron · Dublin, IrelandDirectorJudith M. Matthews · Dublin, IrelandExec · PromoterPaul R. Edick · Dublin, IrelandDirectorMichael W. Dunne · Dublin, IrelandExec · PromoterCorey N. Fishman · Dublin, IrelandExec · Director · PromoterRonald M. Hunt · Dublin, IrelandDirectorBrenton K. Ahrens · Dublin, IrelandDirectorGreg Nielsen · Round Rock, TXDirectorRick Dubois · Littleton, COExec · PromoterIcbp Iv GP, LLC · San Francisco, CAExec · Director · PromoterPatrick Malloy · Indianapolis, INDirectorGeorge Devidze · Columbus, INExec · PromoterCarrie Pumphrey · Columbus, INDirectorRobert M. Steers · NEW YORK, NYExec · Director · PromoterErich A. Mohr · Victoria, British Columbia, CanadaExec · Director · PromoterMichael A. Tharp · Oklahoma City, OKDirectorRobert G. Heard · Oklahoma City, OKDirectorKraettli L. Epperson · Oklahoma City, OKExec · PromoterSteve Chapman · Grand Cayman, Cayman IslandsDirectorJohn Legat · London, United KingdomDirectorPascal Costantini · London, United KingdomDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗